Common Stock, Shares, Outstanding of ZEVRA THERAPEUTICS, INC. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ZEVRA THERAPEUTICS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • ZEVRA THERAPEUTICS, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 56,854,781, a 5.9% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ZEVRA THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 56,854,781 +3,184,072 +5.9% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 56,217,722 +2,990,358 +5.6% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 55,084,204 +13,092,740 +31% 30 Jun 2025 10-Q 05 Nov 2025 2025 Q3
Q1 2025 54,679,363 +12,828,869 +31% 31 Mar 2025 10-Q 05 Nov 2025 2025 Q3
Q4 2024 53,670,709 +12,136,041 +29% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 53,227,364 +17,015,654 +47% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 41,991,464 +8,063,459 +24% 30 Jun 2024 10-Q 13 Nov 2024 2024 Q3
Q1 2024 41,850,494 +7,968,690 +24% 31 Mar 2024 10-Q 13 Nov 2024 2024 Q3
Q4 2023 41,534,668 +6,994,364 +20% 31 Dec 2023 10-K 09 Mar 2026 2025 FY
Q3 2023 36,211,710 +1,710,566 +5% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 33,928,005 -561,309 -1.6% 30 Jun 2023 10-Q 07 Nov 2023 2023 Q3
Q1 2023 33,881,804 -541,693 -1.6% 31 Mar 2023 10-Q 07 Nov 2023 2023 Q3
Q4 2022 34,540,304 -465,336 -1.3% 31 Dec 2022 10-K 12 Mar 2025 2024 FY
Q3 2022 34,501,144 -816,169 -2.3% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 34,489,314 -488,609 -1.4% 30 Jun 2022 10-Q 10 Nov 2022 2022 Q3
Q1 2022 34,423,497 +5,943,341 +21% 31 Mar 2022 10-Q 10 Nov 2022 2022 Q3
Q4 2021 35,005,640 +30,468,319 +672% 31 Dec 2021 10-K 01 Apr 2024 2023 FY
Q3 2021 35,317,313 -37,196,991 -51% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 34,977,923 -32,245,990 -48% 30 Jun 2021 10-Q 10 Nov 2021 2021 Q3
Q1 2021 28,480,156 -28,279,955 -50% 31 Mar 2021 10-Q 10 Nov 2021 2021 Q3
Q4 2020 4,537,321 +2,265,439 +100% 31 Dec 2020 10-K 07 Mar 2023 2022 FY
Q3 2020 72,514,304 +40,126,922 +124% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 67,223,913 +38,365,370 +133% 30 Jun 2020 10-Q 30 Oct 2020 2020 Q3
Q1 2020 56,760,111 +28,783,288 +103% 31 Mar 2020 10-Q 30 Oct 2020 2020 Q3
Q4 2019 2,271,882 +618,457 +37% 31 Dec 2019 10-K 31 Mar 2022 2021 FY
Q3 2019 32,387,382 +16,345,364 +102% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 28,858,543 +12,953,397 +81% 30 Jun 2019 10-Q 14 Nov 2019 2019 Q3
Q1 2019 27,976,823 +12,871,975 +85% 31 Mar 2019 10-Q 14 Nov 2019 2019 Q3
Q4 2018 1,653,425 -13,004,005 -89% 31 Dec 2018 10-K 12 Mar 2021 2020 FY
Q3 2018 16,042,018 +1,384,588 +9.4% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 15,905,146 +1,247,716 +8.5% 30 Jun 2018 10-Q 10 Aug 2018 2018 Q2
Q1 2018 15,104,848 +457,866 +3.1% 31 Mar 2018 10-Q 11 May 2018 2018 Q1
Q4 2017 14,657,430 +10,448 +0.07% 31 Dec 2017 10-K 28 Feb 2020 2019 FY
Q3 2017 14,657,430 +10,448 +0.07% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 14,657,430 +10,448 +0.07% 30 Jun 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 14,646,982 +148,052 +1% 31 Mar 2017 10-Q 22 May 2017 2017 Q1
Q4 2016 14,646,982 +156,028 +1.1% 31 Dec 2016 10-K 01 Mar 2019 2018 FY
Q3 2016 14,646,982 +405,420 +2.8% 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 14,646,982 +418,581 +2.9% 30 Jun 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 14,498,930 +12,107,728 +506% 31 Mar 2016 10-Q 13 May 2016 2016 Q1
Q4 2015 14,490,954 +12,109,913 +509% 31 Dec 2015 10-K 30 Mar 2018 2017 FY
Q3 2015 14,241,562 30 Sep 2015 10-Q 13 Nov 2015 2015 Q3
Q2 2015 14,228,401 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 2,391,202 31 Mar 2015 10-Q 29 May 2015 2015 Q1
Q4 2014 2,381,041 0 0% 31 Dec 2014 10-K 30 Mar 2018 2017 FY
Q4 2013 2,381,041 31 Dec 2013 10-K 10 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.